Mangoceuticals, Inc. SEC filings MGRX

Mangoceuticals, Inc. has 240 filings in SEC EDGAR's recent list, going back to Aug 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (material agreement). The company's fiscal year ends on December 31.

Mangoceuticals, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Oct 9, 2026 Oct 8, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Oct 1, 2026 Sep 30, 2026
8-K Current report
Agreement ended
Aug 21, 2026 Aug 19, 2026
8-K Current report
Other events
Aug 4, 2026 Aug 4, 2026
8-K Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Jul 30, 2026 Jul 28, 2026
8-K Current report
Material agreement, Unregistered share sale
Jul 2, 2026 Jun 29, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 17, 2026 Mar 16, 2026
8-K Current report
Regulation FD disclosure
Feb 23, 2026 Feb 23, 2026
8-K Current report
Regulation FD disclosure
Feb 19, 2026 Feb 19, 2026
8-K Current report
Listing notice
Feb 6, 2026 Feb 4, 2026
8-K Current report
Material agreement, Unregistered share sale
Dec 19, 2025 Dec 18, 2025
8-K Current report
Material agreement, Other events
Dec 19, 2025 Dec 17, 2025
8-K Current report
Material agreement, New debt
Dec 10, 2025 Dec 4, 2025
8-K Current report
Other events
Nov 14, 2025 Nov 13, 2025
8-K Current report
Other events
Nov 13, 2025 Nov 13, 2025
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Officer or director change
Oct 29, 2025 Sep 15, 2025
8-K Current report
Officer or director change
Sep 12, 2025 Sep 9, 2025
8-K Current report
Material agreement, Unregistered share sale
Sep 2, 2025 Aug 26, 2025
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale
Aug 4, 2025 Jul 30, 2025
8-K Current report
Material agreement, Unregistered share sale
Jul 23, 2025 Jun 10, 2025
8-K Current report
Bylaw or fiscal year change
Jul 10, 2025 Jul 3, 2025
8-K Current report
Officer or director change
Jul 3, 2025 Jul 1, 2025
8-K Current report
Unregistered share sale
Jun 10, 2025 Jun 2, 2025
8-K Current report
Material agreement, Unregistered share sale
May 30, 2025 May 15, 2025
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets
May 23, 2025 May 22, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
May 6, 2025 Apr 28, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
Apr 25, 2025 Apr 24, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Apr 17, 2025 Apr 11, 2025
8-K Current report
Officer or director change
Apr 11, 2025 Apr 10, 2025
8-K Current report
Unregistered share sale
Apr 8, 2025 Mar 28, 2025
8-K Current report
Unregistered share sale
Apr 2, 2025 Mar 28, 2025
8-K Current report
Unregistered share sale
Mar 28, 2025 Mar 25, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Mar 25, 2025 Mar 20, 2025
8-K Current report
Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Mar 19, 2025 Mar 17, 2025
8-K Current report
Material agreement, Unregistered share sale
Feb 19, 2025 Feb 14, 2025
8-K Current report
Material agreement, Unregistered share sale
Feb 12, 2025 Feb 7, 2025
8-K Current report
Other events
Feb 12, 2025 Feb 12, 2025
8-K Current report
Unregistered share sale, Officer or director change
Feb 7, 2025 Feb 3, 2025
8-K Current report
Material agreement, Unregistered share sale
Jan 31, 2025 Jan 27, 2025
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Jan 21, 2025 Jan 15, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jan 15, 2025 Jan 9, 2025
8-K Current report
Material agreement, Unregistered share sale
Jan 8, 2025 Dec 31, 2024
8-K Current report
Material agreement, Unregistered share sale
Dec 26, 2024 Dec 18, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Other events
Dec 19, 2024 Dec 13, 2024
8-K Current report
Material agreement, Unregistered share sale
Dec 6, 2024 Dec 2, 2024
8-K Current report
Officer or director change
Nov 12, 2024 Nov 11, 2024
8-K Current report
Other events
Oct 31, 2024 Oct 30, 2024
8-K Current report
Unregistered share sale
Oct 25, 2024 Oct 18, 2024
8-K Current report
Material agreement, New debt, Other events
Oct 22, 2024 Oct 18, 2024
8-K Current report
Regulation FD disclosure
Oct 21, 2024 Oct 21, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Oct 11, 2024 Oct 8, 2024
8-K Current report
Other events
Oct 3, 2024 Oct 3, 2024
8-K Current report
Unregistered share sale
Oct 2, 2024 Aug 15, 2024
8-K Current report
Other events
Oct 1, 2024 Oct 1, 2024
8-K Current report
Unregistered share sale
Sep 27, 2024 Sep 26, 2024
8-K Current report
Unregistered share sale, Officer or director change
Aug 23, 2024 Aug 22, 2024
8-K Current report
Results of operations
Aug 15, 2024 Aug 14, 2024
8-K Current report
Material agreement, Other events
Jul 11, 2024 Jul 9, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jul 2, 2024 Apr 26, 2024
8-K Current report
Shareholder vote results
Jun 18, 2024 Jun 17, 2024
8-K Current report
Unregistered share sale, Officer or director change
Jun 5, 2024 Jun 3, 2024
8-K Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change, Other events
May 2, 2024 Apr 29, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 25, 2024 Apr 19, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 11, 2024 Apr 5, 2024
8-K Current report
Officer or director change, Shareholder vote results
Mar 26, 2024 Mar 25, 2024
8-K Current report
Other events
Jan 25, 2024 Jan 24, 2024
8-K Current report
Other events
Jan 23, 2024 Jan 18, 2024
8-K Current report
Officer or director change
Jan 2, 2024 Dec 28, 2023
8-K Current report
Material agreement, Other events
Dec 19, 2023 Dec 15, 2023
8-K Current report
Material agreement, Unregistered share sale
Dec 11, 2023 Dec 10, 2023
8-K Current report
Listing notice
Nov 7, 2023 Nov 3, 2023
8-K Current report
Listing notice
Nov 1, 2023 Oct 30, 2023
8-K Current report
Results of operations
Oct 19, 2023 Oct 19, 2023
8-K Current report
Officer or director change
Oct 4, 2023 Oct 3, 2023
8-K Current report
Material agreement
Sep 21, 2023 Sep 15, 2023
8-K Current report
Material agreement, Unregistered share sale
Sep 8, 2023 Sep 1, 2023
8-K Current report
Unregistered share sale
Jun 23, 2023 Jun 21, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
May 4, 2023 May 1, 2023

Showing 78 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
MGRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TX
Headquarters
Dallas, TX
SEC filer status
, Emerging growth company
SEC CIK
1938046
Former names
MANGOCEUTICALS, INC. (until Oct 9, 2026)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.